The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
June 19th 2025
Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte stimulator and a proliferation-inducing ligand, to treat the B-cell–mediated autoimmune disease, generalized myasthenia gravis.
BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response
May 26th 2016Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.
Read More
What We're Reading: South Carolina Passes 20-Week Abortion Ban
May 26th 2016What we're reading, May 26, 2016: South Carolina passes a 20-week abortion ban, while Georgia's own law faces a new challenge; the FDA delays its decision on a controversial drug for Duchenne muscular dystrophy; and report highlights how Cover Oregon was mishandled.
Read More